Breaking News Instant updates and real-time market news.

EBIO

Eleven Biotherapeutics

$2.50

0.02 (0.81%)

16:51
11/18/16
11/18
16:51
11/18/16
16:51

Flagship lowers stake in Eleven Biotherapeutics to 6.9%

EBIO Eleven Biotherapeutics
$2.50

0.02 (0.81%)

01/19/16
LEER
01/19/16
DOWNGRADE
Target $1.09
LEER
Market Perform
Eleven Biotherapeutics downgraded to Market Perform from Outperform at Leerink
Leerink analyst Jason Gerberry downgraded Eleven Biotherapeutics to Market Perform after EBI-005 missed its primary endpoint a Phase 3 allergic conjunctivitis trial. The analyst expects the stock to trade at or below its unrestricted cash value of $1.09.
01/19/16
01/19/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Apple Hospitality REIT (APLE) downgraded to Sell from Neutral at Ladenburg... Arch Capital (ACGL) downgraded to Neutral from Outperform at Macquarie... Atmel (ATML) downgraded to Equal Weight from Overweight at Morgan Stanley... BAE Systems (BAESY) downgraded to Underperform from Neutral at Credit Suisse... Bed Bath & Beyond (BBBY) downgraded to Underweight from Hold at BB&T... Best Buy (BBY) downgraded to Equal Weight at Morgan Stanley... CDK Global (CDK) downgraded to Underweight from Equal Weight at Morgan Stanley... Chesapeake Lodging (CHSP) downgraded to Sell from Neutral at Ladenburg... Citrix (CTXS) downgraded to Underweight from Equal Weight at Morgan Stanley... Comstock Resources (CRK) downgraded to Hold from Accumulate at KLR Group... Cypress Energy (CELP) downgraded to Hold from Buy at Stifel... Dunkin' Brands (DNKN) downgraded to Market Perform from Outperform at William Blair... Eleven Biotherapeutics (EBIO) downgraded to Market Perform from Outperform at Leerink... Equity Residential (EQR) downgraded on valuation, rental markets at JMP Securities... Express Scripts (ESRX) downgraded to Market Perform from Outperform at Leerink... LaSalle Hotel (LHO) downgraded to Sell from Neutral at Ladenburg... MSG Networks (MSGN) downgraded to Sell from Hold at Stifel... Madison Square Garden (MSG) downgraded on valuation at Stifel... McCormick (MKC) downgraded to Underweight from Neutral at JPMorgan... Methanex (MEOH) downgraded to Neutral from Buy at Monness Crespi... Nuverra Environmental (NES) downgraded to Hold from Buy at Stifel... OGE Energy (OGE) downgraded to Hold from Buy at Tudor Pickering... Party City (PRTY) downgraded to Equal Weight at Morgan Stanley... Pebblebrook Hotel (PEB) downgraded to Sell from Neutral at Ladenburg... Progressive (PGR) downgraded to Market Perform from Outperform at Bernstein... RLJ Lodging Trust (RLJ) downgraded to Sell from Neutral at Ladenburg... ResMed (RMD) downgraded to Underweight from Equal Weight at Barclays... Rex Energy (REXX) downgraded to Hold from Buy at KLR Group... SM Energy (SM) downgraded to Equalweight from Overweight at Capital One... Sally Beauty (SBH) downgraded to Equal Weight at Morgan Stanley... Santander Brasil (BSBR) downgraded to Reduce from Hold at HSBC... Sarepta (SRPT) downgraded to Sector Perform from Outperform at RBC Capital... Smith & Nephew (SNN) downgraded to Hold from Buy at Deutsche Bank... Sotherly Hotels (SOHO) downgraded to Sell from Buy at Ladenburg... Southwestern Energy (SWN) downgraded to Equalweight from Overweight at Capital One... St. Jude Medical (STJ) downgraded to Market Perform from Outperform at Wells Fargo... Stone Energy (SGY) downgraded to Underweight from Equalweight at Capital One... TerraForm Power (TERP) downgraded to Neutral from Buy at BofA/Merrill... Timken (TKR) downgraded to Hold from Buy at BB&T... Triangle Petroleum (TPLM) downgraded to Hold from Buy at KLR Group... UDR, Inc. (UDR) downgraded at JMP Securities... W&T Offshore (WTI) downgraded to Underweight from Equalweight at Capital One... WPX Energy (WPX) downgraded to Equalweight from Overweight at Capital One... Whiting Petroleum (WLL) downgraded to Equalweight from Overweight at Capital One.
01/20/16
SBSH
01/20/16
DOWNGRADE
Target $1
SBSH
Neutral
Eleven Biotherapeutics downgraded to Neutral from Buy at Citi
Citi analyst Liav Abraham downgraded Eleven Biotherapeutics to Neutral saying the Phase III trial failure for EBI-005 in allergic conjunctivitis raises questions about the company's longer term viability. The analyst cut his price target for the shares to $1.
01/20/16
01/20/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: American Midstream Partners (AMID) downgraded to Hold from Buy at Wunderlich... Armstrong World (AWI) downgraded to Underweight from Equal Weight at Barclays... Barracuda (CUDA) downgraded to Neutral from Buy at Guggenheim... Clayton Williams (CWEI) downgraded to Underperform at Raymond James... Crescent Point Energy (CPG) downgraded to Equal Weight from Overweight at Barclays... Eleven Biotherapeutics (EBIO) downgraded to Neutral from Buy at Citi... Erste Group Bank (EBKDY) downgraded to Neutral from Conviction Buy at Goldman... Fluidigm (FLDM) downgraded to Market Perform from Outperform at Cowen... Fortinet (FTNT) downgraded to Neutral from Overweight at Piper Jaffray... Julius Baer (JBAXY) downgraded to Neutral from Conviction Buy at Goldman... LifePoint (LPNT) downgraded to Neutral from Buy at Goldman... M.D.C. Holdings (MDC) downgraded to Equal Weight from Overweight at Barclays... Parker-Hannifin (PH) downgraded to Hold from Buy at Jefferies... Prudential (PRU) downgraded to Neutral from Buy at BofA/Merrill... Radian Group (RDN) downgraded to Neutral from Outperform at Macquarie... Ruckus Wireless (RKUS) downgraded to Neutral from Buy at Guggenheim... Synaptics (SYNA) downgraded to Perform from Outperform at Oppenheimer... Tiffany (TIF) downgraded to Neutral from Buy at Goldman... Timken (TKR) downgraded to Hold from Buy at Jefferies... Univar (UNVR) downgraded to Neutral from Buy at Goldman... Vale (VALE) downgraded to Hold from Buy at HSBC... Western Gas Equity (WGP) downgraded to Hold from Buy at Wunderlich... Whitecap Resources (SPGYF) downgraded to Equal Weight from Overweight at Barclays.

TODAY'S FREE FLY STORIES

MA

MasterCard

$110.74

1.3 (1.19%)

08:01
02/24/17
02/24
08:01
02/24/17
08:01
Hot Stocks
MasterCard to integrate Masterpass into Gulf Oil's Gulf Pay »

Mastercard announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

VALE

Vale

$10.75

-0.49 (-4.36%)

08:01
02/24/17
02/24
08:01
02/24/17
08:01
Options
Vale put buyer realizes 25% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SATS

EchoStar

$55.24

-0.29 (-0.52%)

08:01
02/24/17
02/24
08:01
02/24/17
08:01
Earnings
EchoStar reports Q4 EPS 40c, consensus 38c »

Reports Q4 revenue $740M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLS

Flowserve

$46.78

-1.87 (-3.84%)

08:00
02/24/17
02/24
08:00
02/24/17
08:00
Hot Stocks
Flowserve names Jay Roueche interim CEO, effective immediately »

Flowserve Corporation,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALE

Vale

$10.75

-0.49 (-4.36%)

08:00
02/24/17
02/24
08:00
02/24/17
08:00
Periodicals
Breaking Periodicals news story on Vale »

Vale CEO Ferreira to step…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZYNE

Zynerba

$22.10

0.27 (1.24%)

07:59
02/24/17
02/24
07:59
02/24/17
07:59
Initiation
Zynerba initiated  »

Zynerba initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

NGVT

Ingevity

$54.35

-2.06 (-3.65%)

07:58
02/24/17
02/24
07:58
02/24/17
07:58
Recommendations
Ingevity analyst commentary  »

Ingevity weakness creates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USM

U.S. Cellular

$44.84

-0.37 (-0.82%)

07:58
02/24/17
02/24
07:58
02/24/17
07:58
Earnings
U.S. Cellular sees FY17 revenue $3.8B-$4B, consensus $4.05B »

Sees FY17 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

BSX

Boston Scientific

$24.48

-0.68 (-2.70%)

07:57
02/24/17
02/24
07:57
02/24/17
07:57
Recommendations
Boston Scientific analyst commentary  »

Selloff in Boston…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 17

    Mar

  • 04

    May

USM

U.S. Cellular

$44.84

-0.37 (-0.82%)

07:57
02/24/17
02/24
07:57
02/24/17
07:57
Earnings
U.S. Cellular reports Q4 EPS (7c), consensus (25c) »

Reports Q4 revenue $991M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

BMY

Bristol-Myers

$55.77

0.42 (0.76%)

07:57
02/24/17
02/24
07:57
02/24/17
07:57
Hot Stocks
Bristol-Myers' Abatacept designated as orphan treatment of IIM »

Bristol-Myers'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 17

    Mar

  • 01

    Apr

TDS

Telephone and Data

$32.72

-0.03 (-0.09%)

07:56
02/24/17
02/24
07:56
02/24/17
07:56
Earnings
Telephone and Data sees FY17 revenue $5.015B-$5.265B, consensus $5.29B »

Sees FY17 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 06

    Mar

JNJ

Johnson & Johnson

$120.90

2.18 (1.84%)

07:55
02/24/17
02/24
07:55
02/24/17
07:55
Hot Stocks
Janssen's Stelara designated as orphan treatment of pediatric ulcerative colitis »

Janssen's Stelara…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 27

    Feb

  • 09

    Mar

  • 14

    Mar

  • 27

    Mar

NVRO

Nevro

$94.25

-2.26 (-2.34%)

07:55
02/24/17
02/24
07:55
02/24/17
07:55
Recommendations
Nevro analyst commentary  »

Nevro price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RSPP

RSP Permian

$40.36

-0.55 (-1.34%)

07:55
02/24/17
02/24
07:55
02/24/17
07:55
Conference/Events
RSP Permian to hold a special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 28

    Feb

  • 20

    Mar

ETN

Eaton

$72.12

-0.38 (-0.52%)

07:55
02/24/17
02/24
07:55
02/24/17
07:55
Conference/Events
Eaton to host analyst meeting »

Analyst meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 07

    Mar

TDS

Telephone and Data

$32.72

-0.03 (-0.09%)

07:54
02/24/17
02/24
07:54
02/24/17
07:54
Earnings
Telephone and Data reports Q4 EPS (5c), consensus (5c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 06

    Mar

TDS

Telephone and Data

$32.72

-0.03 (-0.09%)

07:51
02/24/17
02/24
07:51
02/24/17
07:51
Hot Stocks
Telephone and Data raises quarterly dividend to 15.5c per share »

Payment will be made on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 06

    Mar

TERP

TerraForm Power

$11.40

-0.16 (-1.38%)

07:51
02/24/17
02/24
07:51
02/24/17
07:51
Earnings
TerraForm Power reports Q3 EPS (29c), consensus (16c) »

Reports Q3 revenue $178M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHOO

Steven Madden

07:50
02/24/17
02/24
07:50
02/24/17
07:50
Recommendations
Steven Madden analyst commentary  »

Steven Madden price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

PEG

PSEG

$44.25

-0.02 (-0.05%)

07:49
02/24/17
02/24
07:49
02/24/17
07:49
Earnings
PSEG reports Q4 adjusted EPS 54c, consensus 53c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$136.53

-0.58 (-0.42%)

07:49
02/24/17
02/24
07:49
02/24/17
07:49
Recommendations
Apple analyst commentary  »

Apple average selling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

SPLK

Splunk

$64.90

-0.08 (-0.12%)

07:49
02/24/17
02/24
07:49
02/24/17
07:49
Recommendations
Splunk analyst commentary  »

Splunk should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

PSO

Pearson

$8.10

0.22 (2.79%)

07:48
02/24/17
02/24
07:48
02/24/17
07:48
Hot Stocks
Pearson to rebase dividend from 2017 onwards »

Pearson said: " As…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSO

Pearson

$8.10

0.22 (2.79%)

07:47
02/24/17
02/24
07:47
02/24/17
07:47
Earnings
Pearson backs 2017 outlook, says early trading in line with expectations »

Pearson said its 2017…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.